CompletedNot Applicable

Detecting Absence Seizures Using Eye Tracking

United States150 participantsStarted 2020-07-15

Plain-language summary

The goal of this study is to develop a comfortable system that uses a wearable eye-tracker similar to eyeglasses to assist people with epilepsy in counting and measuring the severity of seizures. Participants will wear an eye-tracker during a routine EEG.

Who can participate

Age range

4 Years – 100 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Provision of signed and dated informed consent form- per local IRB
. Stated willingness to comply with all study procedures including the clicker test and availability for the duration of the study
. Male or female, aged 4-100
. Experience known typical absence seizures as defined by the ILAE 2017 classification or referred to EEG lab for staring spell or concern for absence seizure
. Scheduled for clinical EEG observation

Exclusion criteria

. Intolerant of wearing or unable to wear the eyeglasses
. Autism or other developmental disorder that the PI thinks will interfere with data collection
. History of aggression that the PI thinks will interfere with data collection
. History of not tolerating EEG that the PI thinks will interfere with data collection
. Unable to give consent (for individuals ≥ 18 years old) unless they have an adult with power of attorney to consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Eysz algorithm to detect absence seizures

Timeframe: 1 hour

Trial details

NCT IDNCT04439656

SponsorRachel Kuperman

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-06-28

View on ClinicalTrials.gov More Epilepsy, Generalized trials